MD Magazine® Staff

HPV vaccination rates continue to lag significantly behind rates for the other vaccines universally recommended for adolescents.

A coalition announced yesterday the beginning of a Phase 2b trial of MVA85A, a new investigational vaccine for tuberculosis.

Antidepressants are increasingly being prescribed by nonpsychiatrists without an accompanying psychiatric diagnosis, a new study finds.

AB Science has recruited its first patient in a phase 2b/3 study of its orally administered drug masitinib as a treatment for rheumatoid arthritis.

Scientists have discovered an antibody that is effective against several dozen different strains of influenza.

Antares Pharma, Inc. has announced positive results of an auto-injector that delivers a rapid subcutaneous injection of methotrexate.

A group of French scientists have announced promising results of a vaccine for the debilitating hepatitis C virus.

The FDA has accepted a new drug application for Levadex (dihydroergotamine), an orally inhaled drug for the acute treatment of migraine in adults.

Chef Seamus Mullen has found relief from rheumatoid arthritis through medication-and a diet that emphasizes fresh ingredients from Spanish cuisine.

Brain scans have detected brain chemistry changes associated with depression in heavy smokers in early withdrawal.

The FDA has delayed ruling on whether to allow use of Pfizer's Prevnar 13 vaccine by adults 50 and older until January 2012.

Varenicline substantially increased the risk of a serious cardiovascular event even among smokers without heart disease.

Today the FDA approved an expanded indication of the RX Acculink carotid stent.

Just in time for Halloween (ok, so we're a day late), a post about candy, children, and behavior problems.

Could telephone-based therapy management really make a difference in clinical outcomes.

When it comes to large-scale adverse events in the hospital setting, full disclosure is still the best strategy, according to a commentary published in the New England Journal of Medicine.

Massachusetts has recently expanded its prescription drug monitoring system, according to an article in The Boston Globe published August 12.

Six months later, living conditions for thousands of Haitians remain dire.

Val Jones, MD, founder and creator of the blog Better Health, and physician with DocTalker Family Medicine, a pay-as-you-go, time-based practice, discusses what it's like to be a physician in an unconventional practice. Jones, like many physicians at DocTalker, was a patient before asking to come aboard as a member.

Last week Jazz Pharmaceuticals, Inc. announced that the FDA has accepted for filing the New Drug Application for JZP-6 (sodium oxybate) for the treatment of fibromyalgia.

Through the haze of the severe symptoms migraine patients experience shines a new light of the possibility of protection from a deadly cancer.

Auxilium Pharmaceuticals, Inc. just announced that it has received marketing approval from the FDA for XIAFLEX(TM) (collagenase clostridium histolyticum), a novel, first-in-class, orphan-designated, biologic, for the treatment of adult Dupuytren's contracture patients with a palpable cord.

Paul McMaster, a Doctors Without Borders/Médecins Sans Frontières surgeon, describes what he and his team have seen and done since they arrived in Port-au-Prince to bring emergency medical care to earthquake survivors on January 15.

A Doctors Without Borders/Médecins Sans Frontières cargo plane carrying 12 tons of medical equipment, including drugs, surgical supplies and two dialysis machines, was turned away three times from Port-au-Prince airport since Sunday night despite repeated assurances of its ability to land there.

Doctors Without Borders/Médecins Sans Frontières teams in Port-au-Prince are still under great pressure.

Doctors Without Borders/Médecins Sans Frontières staff work 24 hours a day to treat as many patients injured in the January 12 earthquake as possible, but the needs are huge and there are delays in receiving crucial supplies.

Doctors Without Borders/Médecins Sans Frontières urges that its cargo planes carrying essential medical and surgical material be allowed to land in Port-au-Prince in order to treat thousands of wounded waiting for vital surgical operations.

Isabelle Jeanson, a Doctors Without Borders/Médecins Sans Frontières emergency communications officer, has been with the MSF teams in Port-au-Prince since January 15. Here she describes the situation as of January 17.

Here are some general facts about last week's earthquake in Haiti and the aid that has been given by other countries around the world.

The FDA approved Actemra (tocilizumab) on Friday to treat adults with moderate to severe rheumatoid arthritis who have not adequately responded to or cannot tolerate other approved drug classes for rheumatoid arthritis.